These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14753245)

  • 1. Budesonide Modulite: improving the changeover to CFC-free treatments.
    Magnussen H
    Respir Med; 2003 Nov; 97 Suppl D():S1-3. PubMed ID: 14753245
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparing for a change in metered-dose inhalers. National Asthma Education and Prevention Program CFC Phaseout Working Group.
    Minn Med; 1998 Feb; 81(2):26-7. PubMed ID: 9505495
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical comparability between the CFC and HFA budesonide pressurised metered-dose inhalers in paediatric patients with asthma: a randomised controlled trial.
    Escribano A; Tutuncu A; Löhr I; Carlholm M; Polanowski T
    Curr Med Res Opin; 2006 Jun; 22(6):1085-92. PubMed ID: 16846541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchoprotective and bronchodilator effects of an HFA pMDI vs. a CFC pMDI and a DPI containing formoterol in asthma patients.
    Langley SJ; Houghton CM; Singh SD
    Respiration; 2005; 72 Suppl 1():35-7. PubMed ID: 15915011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The change to non-CFC metered dose inhalers.
    Rubinfeld A
    Aust Fam Physician; 1997 Dec; 26(12):1412-4. PubMed ID: 9470296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [After prohibition of dose aerosol inhalers with FCKW. Powder inhaler improves steroid therapy].
    MMW Fortschr Med; 2003 Mar; 145(11):61. PubMed ID: 12688205
    [No Abstract]   [Full Text] [Related]  

  • 7. Modulite technology: pharmacodynamic and pharmacokinetic implications.
    Woodcock A; Acerbi D; Poli G
    Respir Med; 2002 Aug; 96 Suppl D():S9-15. PubMed ID: 12201080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study.
    Houghton CM; Langley SJ; Singh SD; Holden J; Monici Preti AP; Acerbi D; Poli G; Woodcock A
    Br J Clin Pharmacol; 2004 Oct; 58(4):359-66. PubMed ID: 15373928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budesonide administered using chlorofluorocarbon and hydrofluoroalkane pressurized metered-dose inhalers: pharmacokinetics, pharmacodynamics and clinical equivalence.
    Singh D; Tutuncu A; Lohr I; Carlholm M; Polanowski T
    Int J Clin Pharmacol Ther; 2007 Sep; 45(9):485-95. PubMed ID: 17907591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical studies in asthmatics with a new non-extra fine HFA formulation of beclometasone dipropionate (BDP Modulite).
    Bousquet J; Cantini L
    Respir Med; 2002 Aug; 96 Suppl D():S17-27. PubMed ID: 12201078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pressurized metered dose inhaler (pMDI) remains the most commonly prescribed device for the delivery of inhaled asthma medications.
    Braunstein G; Sharma R
    Respir Med; 2000 Jun; 94 Suppl B():S1-2. PubMed ID: 10919678
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medications.
    Boccuzzi SJ; Wogen J; Roehm JB
    Clin Ther; 2000 Feb; 22(2):237-47. PubMed ID: 10743983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward international consensus on clinical aerosol administration.
    Pierson DJ
    Chest; 1991 Oct; 100(4):1100-1. PubMed ID: 1680609
    [No Abstract]   [Full Text] [Related]  

  • 14. Switching to CFC-free inhalers.
    Weller T
    Prof Nurse; 1999 Nov; 15(2):73. PubMed ID: 10765307
    [No Abstract]   [Full Text] [Related]  

  • 15. CFC Phase-Out and the Chiesi Solution.
    Huchon G; Fabbri LM
    Respiration; 2005; 72 Suppl 1():1-2. PubMed ID: 15915005
    [No Abstract]   [Full Text] [Related]  

  • 16. The environmental impact of chlorofluorocarbon use in metered dose inhalers.
    Balmes JR
    Chest; 1991 Oct; 100(4):1101-2. PubMed ID: 1914565
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhaled budesonide: placebo problems.
    Elwood T; Morris B
    Acad Emerg Med; 1998 Sep; 5(9):943-4. PubMed ID: 9754511
    [No Abstract]   [Full Text] [Related]  

  • 18. [Facilitating conversion in budesonide inhalation therapy. New propellant-free inhalation system].
    MMW Fortschr Med; 2002 Oct; 144(40):48. PubMed ID: 12440298
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparable efficacy of administration with face mask or mouthpiece of nebulized budesonide suspension for infants and young children with persistant asthma.
    Lipworth BJ; Jackson CM
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1277-8. PubMed ID: 11316669
    [No Abstract]   [Full Text] [Related]  

  • 20. Budesonide turbuhaler for asthma.
    Med Lett Drugs Ther; 1998 Jan; 40(1018):15-6. PubMed ID: 9457158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.